title: Mortality, morbidity, and 1-year outcomes of primary elective total hip arthroplasty.
abstract: No representative data exist on the risks of adverse outcomes of total hip arthroplasty (THA) in the United Kingdom. A prospective observational study of unselected THA operations was carried out in 5 U.K. regions. Adverse outcomes were assessed from the hospital case notes and general practitioners of 1,100 randomly selected patients and from 7,151 patient-completed questionnaires 3 and 12 months after THA. Three-month mortality was 0.4% to 0.7%. Dislocation and thromboembolic complications were about 3% and 4%. Perioperative fracture, sciatic nerve palsy, aseptic loosening, and revision each had a risk of < or = 1%. At 1 year, 2.6% of patients had undergone another operation on the same hip, 11% reported moderate or severe pain in the operated hip, 23% had severe walking restriction, and 11% were dissatisfied with the operation. Patients and surgeons in the United Kingdom should have access to this information when making a decision about THA.
authors.affiliation: Institute of Public Health, Cambridge, United Kingdom.
authors.forename: Olwen
authors.initials: O
authors.lastname: Williams
authors.forename: Ray
authors.initials: R
authors.lastname: Fitzpatrick
authors.forename: Shakoor
authors.initials: S
authors.lastname: Hajat
authors.forename: Barnaby C
authors.initials: BC
authors.lastname: Reeves
authors.forename: Anne
authors.initials: A
authors.lastname: Stimpson
authors.forename: Richard W
authors.initials: RW
authors.lastname: Morris
authors.forename: David W
authors.initials: DW
authors.lastname: Murray
authors.forename: Marianne
authors.initials: M
authors.lastname: Rigge
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Gregg
mesh_terms: D019644:Arthroplasty, Replacement, Hip / Q000401:mortality*; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D009017:Morbidity; D011183:Postoperative Complications / Q000453:epidemiology; D011446:Prospective Studies; D016896:Treatment Outcome